pharmacies de garde
pharmacies de garde with http://www.takeyourmeds.info

pharmacies de garde

Take Your Meds

News for 01-Mar-24

Source: MedicineNet Kids Health General
Down Syndrome May Not Be Big Financial Burden on Families

Source: MedicineNet Kids Health General
Some Kids' Genes Might Make Food Ads More Tempting

Source: MedicineNet Kids Health General
Health Tip: Help Toddlers Develop Stronger Hands

Source: MedicineNet Kids Health General
Rest May Not Be Best for Kids After Concussion

Source: MedicineNet Kids Health General
Used Safely, Donor Breast Milk Can Help Preemie Babies

Source: MedicineNet Kids Health General
Teen Violence Can Be Contagious, Study Contends

Source: MedicineNet Kids Health General
Growth Charts

Source: MedicineNet Kids Health General
Teens May Not Heed Health Warnings on Cigars

Source: MedicineNet Kids Health General
Child Deaths Highlight Choking Dangers Posed by Grapes

Source: MedicineNet Kids Health General
Baby Crib Ads Show Unsafe Practices, Study Says

Search the Web
pharmacies de garde
marketing
supplies
amoxil
validation
discount medicine
drug shop
information on drugs
mental health
pharmaceutical research institute

The Best pharmacies de garde website

All the pharmacies de garde information you need to know about is right here. Presented and researched by http://www.takeyourmeds.info. We've searched the information super highway far and wide to provide you with the best pharmacies de garde site on the internet today. The links below will assist you in your efforts to find the information that you are looking for about
pharmacies de garde.

pharmacies de garde
pharmacies de garde, , pharmacies de garde, , pharmacies de garde,
http://www.medmeet.com/
CLICK HERE RIGHT NOW

pharmacies de garde

Take Your Meds
Most people skip taking their medication at certain times, this is bad for your health. Look to Take Your Meds on time and
Take Your Meds

The pharmacies de garde links on the right side of this page will take you directly to the specific item you need so look around. We have made it easy for you and of course this company stands behind their pharmacies de garde with total satisfaction guarantees

Somewhere on this page you will find the exact pharmacies de garde link you are looking for as we have done extensive research to put the best sources available at your fingertips. Just take a few minutes and you will find exactly the pharmacies de garde information you need.

a Cold; Starve a Tumor

 by: ARA Content

(ARA) - One of the most exciting developments in modern medicine has been the discovery that cancerous tumors have the potential of being "starved" out of existence, or at least into dormancy. Scientists, doctors and, of course, patients, are all anticipating the prospect that cancer patients may take a drug that will stop a tumor in its track by cutting off the blood supply that nourishes it.

At the core of this medical breakthrough was the discovery that every tumor needs to "recruit" its own blood supply to flourish and grow. Scientists also found out that tumors actively "participated" in this process by secreting certain growth chemicals that would attract blood vessels to the tumor. Having identified this process, the next step was to determine if drugs could be created that could somehow arrest or reverse the progress of blood vessels amassing around a tumor.

The result has been a highly dynamic and exciting area of medicine called anti-angiogenesis (meaning "against the formation of new blood vessels") that focuses on inhibiting the growth of cancer by developing drugs that will prevent tumors from growing in size.

Currently, there are several drug companies that are on the cusp of introducing drugs that will work by the process of anti-angiogenesis. Generally speaking, the drugs seek to improve survival rates of cancer patients, as well as increase the length of time that patients survive. And unlike conventional cancer therapies that have punishing side effects, the new drugs seem to demonstrate few or no side effects for most people. Furthermore, some of the studies show that by utilizing both conventional treatments like radiation and/or chemotherapy in conjunction with anti-angiogenesis drugs, the cumulative effect is even more powerful.

One highly regarded company that is at the forefront of developing anti-angiogenesis drugs is Aeterna Laboratories, based in Quebec, Canada and traded on the Nasdaq market under the ticker symbol, AELA. The company's premier product, Neovastat, is currently being tested in clinical trials for a variety of cancers including lung, renal (kidney) and multiple myeloma (bone marrow). The results for the renal and multiple myeloma tests are scheduled to wrap up by the end of 2002 and, if conclusive, will be submitted to the Federal Drug Administration for review.

Out of all the drugs under development, Neovastat is unique because of its multi-functionality, which is its ability to shut down two pathways recognized as being responsible for promoting angiogenesis (in contrast to other drugs which just block one pathway). In clinical trials, Neovastat has been shown to have no side effects in most people. This is obviously a big advantage for people who know the agony of nausea, exhaustion and/or hair loss that can accompany chemotherapy drugs. In tests, Neovastat has been given to people in liquid oral form, generally the preferable form of drug delivery for patients.

If you are a cancer patient interested in clinical trial participation, you can get information about current trials by calling (888)-349-3232 If you are an oncologist, please contact Claude Hariton, Ph.D., vice president of Clinical and Regulatory Affairs at (418) 652-8525 ext. 306. To learn more about anti-angiogenesis drugs and Aeterna Laboratories, visit the Aeterna Web site at www.aeterna.com.

About The Author

Courtesy ARA Content, www.ARAcontent.com; e-mail: info@ARAcontent.com

Google

http://www.medmeet.com/
Go Meetings | Go Antiques | Medical Meetings On The Net | Medical Meetings On The Net | Present On The Net

Talk On The Net   RX Right!   Present On The Net